TNFAIP2 and acute myeloid leukemia: To further validate whether TNFAIP2 expression was linked to AML subtypes and genetic alterations, microarray data (GSE14468) from the GEO database as well as Beat AML dataset were applied to evaluate the TNFAIP2 expression in the distribution of FAB classification, cytogenetic risk stratification and gene mutations.